nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—SLC22A5—Niacin—atherosclerosis	0.298	0.415	CbGbCtD
Tiotropium—CYP2D6—Niacin—atherosclerosis	0.0712	0.0991	CbGbCtD
Tiotropium—CYP2D6—Simvastatin—atherosclerosis	0.0563	0.0784	CbGbCtD
Tiotropium—CYP2D6—Pravastatin—atherosclerosis	0.0551	0.0767	CbGbCtD
Tiotropium—CYP2D6—Lovastatin—atherosclerosis	0.0551	0.0767	CbGbCtD
Tiotropium—CYP3A4—Rosuvastatin—atherosclerosis	0.0385	0.0536	CbGbCtD
Tiotropium—CYP3A4—Ezetimibe—atherosclerosis	0.0385	0.0536	CbGbCtD
Tiotropium—CYP3A4—Simvastatin—atherosclerosis	0.0358	0.0498	CbGbCtD
Tiotropium—CYP3A4—Pravastatin—atherosclerosis	0.035	0.0488	CbGbCtD
Tiotropium—CYP3A4—Lovastatin—atherosclerosis	0.035	0.0488	CbGbCtD
Tiotropium—Leg pain—Lovastatin—atherosclerosis	0.00538	0.0264	CcSEcCtD
Tiotropium—Laryngitis—Niacin—atherosclerosis	0.00296	0.0145	CcSEcCtD
Tiotropium—Glaucoma—Niacin—atherosclerosis	0.00283	0.0139	CcSEcCtD
Tiotropium—Herpes zoster—Niacin—atherosclerosis	0.00283	0.0139	CcSEcCtD
Tiotropium—Skin ulcer—Niacin—atherosclerosis	0.00274	0.0134	CcSEcCtD
Tiotropium—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.0027	0.0132	CcSEcCtD
Tiotropium—Cataract—Lovastatin—atherosclerosis	0.00261	0.0128	CcSEcCtD
Tiotropium—Cataract—Simvastatin—atherosclerosis	0.00244	0.012	CcSEcCtD
Tiotropium—Cataract—Pravastatin—atherosclerosis	0.00221	0.0108	CcSEcCtD
Tiotropium—Arthritis—Lovastatin—atherosclerosis	0.00185	0.00909	CcSEcCtD
Tiotropium—Arthritis—Ezetimibe—atherosclerosis	0.00182	0.00892	CcSEcCtD
Tiotropium—Pain in extremity—Lovastatin—atherosclerosis	0.0018	0.00884	CcSEcCtD
Tiotropium—Pain in extremity—Ezetimibe—atherosclerosis	0.00177	0.00867	CcSEcCtD
Tiotropium—Arthritis—Simvastatin—atherosclerosis	0.00173	0.0085	CcSEcCtD
Tiotropium—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00159	0.00781	CcSEcCtD
Tiotropium—Arthritis—Niacin—atherosclerosis	0.00159	0.00781	CcSEcCtD
Tiotropium—Arthritis—Pravastatin—atherosclerosis	0.00157	0.00769	CcSEcCtD
Tiotropium—Sinusitis—Rosuvastatin—atherosclerosis	0.00154	0.00754	CcSEcCtD
Tiotropium—Rhinitis—Rosuvastatin—atherosclerosis	0.00148	0.00723	CcSEcCtD
Tiotropium—Urinary retention—Niacin—atherosclerosis	0.00147	0.00722	CcSEcCtD
Tiotropium—Pharyngitis—Rosuvastatin—atherosclerosis	0.00146	0.00716	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00142	0.00696	CcSEcCtD
Tiotropium—Dry skin—Niacin—atherosclerosis	0.00142	0.00696	CcSEcCtD
Tiotropium—Dry skin—Pravastatin—atherosclerosis	0.0014	0.00685	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00135	0.00664	CcSEcCtD
Tiotropium—Urinary tract infection—Lovastatin—atherosclerosis	0.00135	0.00662	CcSEcCtD
Tiotropium—Dysphagia—Niacin—atherosclerosis	0.00134	0.00656	CcSEcCtD
Tiotropium—Arrhythmia—Rosuvastatin—atherosclerosis	0.00131	0.00644	CcSEcCtD
Tiotropium—Angina pectoris—Niacin—atherosclerosis	0.0013	0.00639	CcSEcCtD
Tiotropium—Sinusitis—Lovastatin—atherosclerosis	0.0013	0.00639	CcSEcCtD
Tiotropium—Mental disorder—Rosuvastatin—atherosclerosis	0.00129	0.00632	CcSEcCtD
Tiotropium—Angina pectoris—Pravastatin—atherosclerosis	0.00128	0.00629	CcSEcCtD
Tiotropium—Sinusitis—Ezetimibe—atherosclerosis	0.00128	0.00627	CcSEcCtD
Tiotropium—Dysuria—Pravastatin—atherosclerosis	0.00123	0.00604	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00122	0.006	CcSEcCtD
Tiotropium—Sinusitis—Simvastatin—atherosclerosis	0.00122	0.00597	CcSEcCtD
Tiotropium—Pharyngitis—Ezetimibe—atherosclerosis	0.00121	0.00595	CcSEcCtD
Tiotropium—Oedema peripheral—Ezetimibe—atherosclerosis	0.0012	0.00591	CcSEcCtD
Tiotropium—Connective tissue disorder—Ezetimibe—atherosclerosis	0.0012	0.00589	CcSEcCtD
Tiotropium—Angioedema—Rosuvastatin—atherosclerosis	0.00117	0.00574	CcSEcCtD
Tiotropium—Stomatitis—Niacin—atherosclerosis	0.00116	0.0057	CcSEcCtD
Tiotropium—Urinary tract infection—Pravastatin—atherosclerosis	0.00114	0.0056	CcSEcCtD
Tiotropium—Cough—Rosuvastatin—atherosclerosis	0.00112	0.00548	CcSEcCtD
Tiotropium—Angiopathy—Ezetimibe—atherosclerosis	0.00111	0.00544	CcSEcCtD
Tiotropium—Immune system disorder—Ezetimibe—atherosclerosis	0.0011	0.00541	CcSEcCtD
Tiotropium—Mediastinal disorder—Ezetimibe—atherosclerosis	0.0011	0.0054	CcSEcCtD
Tiotropium—Sinusitis—Pravastatin—atherosclerosis	0.0011	0.0054	CcSEcCtD
Tiotropium—Arthralgia—Rosuvastatin—atherosclerosis	0.00109	0.00535	CcSEcCtD
Tiotropium—Myalgia—Rosuvastatin—atherosclerosis	0.00109	0.00535	CcSEcCtD
Tiotropium—Rhinitis—Niacin—atherosclerosis	0.00107	0.00526	CcSEcCtD
Tiotropium—Mental disorder—Ezetimibe—atherosclerosis	0.00107	0.00525	CcSEcCtD
Tiotropium—Malnutrition—Ezetimibe—atherosclerosis	0.00106	0.00522	CcSEcCtD
Tiotropium—Rhinitis—Pravastatin—atherosclerosis	0.00106	0.00518	CcSEcCtD
Tiotropium—Oedema peripheral—Niacin—atherosclerosis	0.00106	0.00517	CcSEcCtD
Tiotropium—Back pain—Lovastatin—atherosclerosis	0.00105	0.00515	CcSEcCtD
Tiotropium—Pharyngitis—Pravastatin—atherosclerosis	0.00105	0.00513	CcSEcCtD
Tiotropium—Infection—Rosuvastatin—atherosclerosis	0.00104	0.00509	CcSEcCtD
Tiotropium—Visual impairment—Niacin—atherosclerosis	0.00103	0.00506	CcSEcCtD
Tiotropium—Back pain—Ezetimibe—atherosclerosis	0.00103	0.00505	CcSEcCtD
Tiotropium—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00103	0.00502	CcSEcCtD
Tiotropium—Vision blurred—Lovastatin—atherosclerosis	0.00102	0.00501	CcSEcCtD
Tiotropium—Mental disorder—Simvastatin—atherosclerosis	0.00102	0.00501	CcSEcCtD
Tiotropium—Visual impairment—Pravastatin—atherosclerosis	0.00102	0.00498	CcSEcCtD
Tiotropium—Eye disorder—Niacin—atherosclerosis	0.001	0.00491	CcSEcCtD
Tiotropium—Angioedema—Lovastatin—atherosclerosis	0.000992	0.00486	CcSEcCtD
Tiotropium—Angioedema—Ezetimibe—atherosclerosis	0.000973	0.00477	CcSEcCtD
Tiotropium—Angiopathy—Niacin—atherosclerosis	0.000972	0.00476	CcSEcCtD
Tiotropium—Vision blurred—Simvastatin—atherosclerosis	0.000957	0.00469	CcSEcCtD
Tiotropium—Arrhythmia—Niacin—atherosclerosis	0.000957	0.00469	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000952	0.00467	CcSEcCtD
Tiotropium—Insomnia—Rosuvastatin—atherosclerosis	0.000946	0.00463	CcSEcCtD
Tiotropium—Arrhythmia—Pravastatin—atherosclerosis	0.000942	0.00462	CcSEcCtD
Tiotropium—Palpitations—Ezetimibe—atherosclerosis	0.000941	0.00461	CcSEcCtD
Tiotropium—Paraesthesia—Rosuvastatin—atherosclerosis	0.000939	0.0046	CcSEcCtD
Tiotropium—Malnutrition—Niacin—atherosclerosis	0.000932	0.00457	CcSEcCtD
Tiotropium—Cough—Ezetimibe—atherosclerosis	0.000929	0.00455	CcSEcCtD
Tiotropium—Angioedema—Simvastatin—atherosclerosis	0.000928	0.00455	CcSEcCtD
Tiotropium—Chest pain—Lovastatin—atherosclerosis	0.000924	0.00453	CcSEcCtD
Tiotropium—Myalgia—Lovastatin—atherosclerosis	0.000924	0.00453	CcSEcCtD
Tiotropium—Arthralgia—Lovastatin—atherosclerosis	0.000924	0.00453	CcSEcCtD
Tiotropium—Dyspepsia—Rosuvastatin—atherosclerosis	0.00092	0.00451	CcSEcCtD
Tiotropium—Hypertension—Ezetimibe—atherosclerosis	0.000919	0.00451	CcSEcCtD
Tiotropium—Chest pain—Ezetimibe—atherosclerosis	0.000906	0.00444	CcSEcCtD
Tiotropium—Myalgia—Ezetimibe—atherosclerosis	0.000906	0.00444	CcSEcCtD
Tiotropium—Arthralgia—Ezetimibe—atherosclerosis	0.000906	0.00444	CcSEcCtD
Tiotropium—Dry mouth—Lovastatin—atherosclerosis	0.000904	0.00443	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0009	0.00441	CcSEcCtD
Tiotropium—Constipation—Rosuvastatin—atherosclerosis	0.000894	0.00438	CcSEcCtD
Tiotropium—Dry mouth—Ezetimibe—atherosclerosis	0.000887	0.00435	CcSEcCtD
Tiotropium—Infection—Lovastatin—atherosclerosis	0.00088	0.00431	CcSEcCtD
Tiotropium—Vision blurred—Niacin—atherosclerosis	0.000879	0.00431	CcSEcCtD
Tiotropium—Vision blurred—Pravastatin—atherosclerosis	0.000865	0.00424	CcSEcCtD
Tiotropium—Arthralgia—Simvastatin—atherosclerosis	0.000864	0.00424	CcSEcCtD
Tiotropium—Chest pain—Simvastatin—atherosclerosis	0.000864	0.00424	CcSEcCtD
Tiotropium—Myalgia—Simvastatin—atherosclerosis	0.000864	0.00424	CcSEcCtD
Tiotropium—Infection—Ezetimibe—atherosclerosis	0.000863	0.00423	CcSEcCtD
Tiotropium—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000855	0.00419	CcSEcCtD
Tiotropium—Nervous system disorder—Ezetimibe—atherosclerosis	0.000852	0.00418	CcSEcCtD
Tiotropium—Angioedema—Niacin—atherosclerosis	0.000852	0.00418	CcSEcCtD
Tiotropium—Skin disorder—Ezetimibe—atherosclerosis	0.000844	0.00414	CcSEcCtD
Tiotropium—Angioedema—Pravastatin—atherosclerosis	0.000839	0.00411	CcSEcCtD
Tiotropium—Syncope—Niacin—atherosclerosis	0.000836	0.0041	CcSEcCtD
Tiotropium—Urticaria—Rosuvastatin—atherosclerosis	0.00083	0.00407	CcSEcCtD
Tiotropium—Oedema—Simvastatin—atherosclerosis	0.000829	0.00406	CcSEcCtD
Tiotropium—Abdominal pain—Rosuvastatin—atherosclerosis	0.000826	0.00405	CcSEcCtD
Tiotropium—Palpitations—Niacin—atherosclerosis	0.000824	0.00404	CcSEcCtD
Tiotropium—Infection—Simvastatin—atherosclerosis	0.000823	0.00404	CcSEcCtD
Tiotropium—Loss of consciousness—Niacin—atherosclerosis	0.000819	0.00402	CcSEcCtD
Tiotropium—Cough—Niacin—atherosclerosis	0.000814	0.00399	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000807	0.00396	CcSEcCtD
Tiotropium—Insomnia—Lovastatin—atherosclerosis	0.000801	0.00393	CcSEcCtD
Tiotropium—Cough—Pravastatin—atherosclerosis	0.000801	0.00393	CcSEcCtD
Tiotropium—Paraesthesia—Lovastatin—atherosclerosis	0.000796	0.0039	CcSEcCtD
Tiotropium—Myalgia—Niacin—atherosclerosis	0.000794	0.00389	CcSEcCtD
Tiotropium—Arthralgia—Niacin—atherosclerosis	0.000794	0.00389	CcSEcCtD
Tiotropium—Hypertension—Pravastatin—atherosclerosis	0.000793	0.00388	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000792	0.00388	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000788	0.00386	CcSEcCtD
Tiotropium—Insomnia—Ezetimibe—atherosclerosis	0.000786	0.00385	CcSEcCtD
Tiotropium—Arthralgia—Pravastatin—atherosclerosis	0.000782	0.00383	CcSEcCtD
Tiotropium—Myalgia—Pravastatin—atherosclerosis	0.000782	0.00383	CcSEcCtD
Tiotropium—Chest pain—Pravastatin—atherosclerosis	0.000782	0.00383	CcSEcCtD
Tiotropium—Paraesthesia—Ezetimibe—atherosclerosis	0.00078	0.00382	CcSEcCtD
Tiotropium—Dyspepsia—Lovastatin—atherosclerosis	0.00078	0.00382	CcSEcCtD
Tiotropium—Dry mouth—Niacin—atherosclerosis	0.000776	0.0038	CcSEcCtD
Tiotropium—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00077	0.00378	CcSEcCtD
Tiotropium—Dyspepsia—Ezetimibe—atherosclerosis	0.000765	0.00375	CcSEcCtD
Tiotropium—Oedema—Niacin—atherosclerosis	0.000761	0.00373	CcSEcCtD
Tiotropium—Constipation—Lovastatin—atherosclerosis	0.000758	0.00371	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000755	0.0037	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00075	0.00368	CcSEcCtD
Tiotropium—Insomnia—Simvastatin—atherosclerosis	0.000749	0.00367	CcSEcCtD
Tiotropium—Oedema—Pravastatin—atherosclerosis	0.000749	0.00367	CcSEcCtD
Tiotropium—Shock—Niacin—atherosclerosis	0.000749	0.00367	CcSEcCtD
Tiotropium—Infection—Pravastatin—atherosclerosis	0.000744	0.00365	CcSEcCtD
Tiotropium—Paraesthesia—Simvastatin—atherosclerosis	0.000744	0.00365	CcSEcCtD
Tiotropium—Constipation—Ezetimibe—atherosclerosis	0.000743	0.00364	CcSEcCtD
Tiotropium—Tachycardia—Niacin—atherosclerosis	0.000743	0.00364	CcSEcCtD
Tiotropium—Pruritus—Rosuvastatin—atherosclerosis	0.00074	0.00363	CcSEcCtD
Tiotropium—Skin disorder—Niacin—atherosclerosis	0.000739	0.00362	CcSEcCtD
Tiotropium—Dyspepsia—Simvastatin—atherosclerosis	0.000729	0.00358	CcSEcCtD
Tiotropium—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000724	0.00355	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000715	0.00351	CcSEcCtD
Tiotropium—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000711	0.00348	CcSEcCtD
Tiotropium—Constipation—Simvastatin—atherosclerosis	0.000709	0.00347	CcSEcCtD
Tiotropium—Urticaria—Lovastatin—atherosclerosis	0.000704	0.00345	CcSEcCtD
Tiotropium—Abdominal pain—Lovastatin—atherosclerosis	0.0007	0.00343	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000693	0.0034	CcSEcCtD
Tiotropium—Dizziness—Rosuvastatin—atherosclerosis	0.000691	0.00339	CcSEcCtD
Tiotropium—Urticaria—Ezetimibe—atherosclerosis	0.00069	0.00338	CcSEcCtD
Tiotropium—Insomnia—Niacin—atherosclerosis	0.000688	0.00337	CcSEcCtD
Tiotropium—Abdominal pain—Ezetimibe—atherosclerosis	0.000687	0.00337	CcSEcCtD
Tiotropium—Paraesthesia—Niacin—atherosclerosis	0.000683	0.00335	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000683	0.00335	CcSEcCtD
Tiotropium—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000678	0.00332	CcSEcCtD
Tiotropium—Insomnia—Pravastatin—atherosclerosis	0.000678	0.00332	CcSEcCtD
Tiotropium—Paraesthesia—Pravastatin—atherosclerosis	0.000673	0.0033	CcSEcCtD
Tiotropium—Dyspepsia—Niacin—atherosclerosis	0.00067	0.00328	CcSEcCtD
Tiotropium—Dyspepsia—Pravastatin—atherosclerosis	0.000659	0.00323	CcSEcCtD
Tiotropium—Rash—Rosuvastatin—atherosclerosis	0.000659	0.00323	CcSEcCtD
Tiotropium—Dermatitis—Rosuvastatin—atherosclerosis	0.000659	0.00323	CcSEcCtD
Tiotropium—Urticaria—Simvastatin—atherosclerosis	0.000658	0.00323	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Niacin—atherosclerosis	0.000657	0.00322	CcSEcCtD
Tiotropium—Abdominal pain—Simvastatin—atherosclerosis	0.000655	0.00321	CcSEcCtD
Tiotropium—Headache—Rosuvastatin—atherosclerosis	0.000655	0.00321	CcSEcCtD
Tiotropium—Hypersensitivity—Lovastatin—atherosclerosis	0.000653	0.0032	CcSEcCtD
Tiotropium—Constipation—Pravastatin—atherosclerosis	0.000641	0.00314	CcSEcCtD
Tiotropium—Hypersensitivity—Ezetimibe—atherosclerosis	0.00064	0.00314	CcSEcCtD
Tiotropium—Pruritus—Lovastatin—atherosclerosis	0.000627	0.00307	CcSEcCtD
Tiotropium—Gastrointestinal pain—Niacin—atherosclerosis	0.000622	0.00305	CcSEcCtD
Tiotropium—Nausea—Rosuvastatin—atherosclerosis	0.000621	0.00304	CcSEcCtD
Tiotropium—Pruritus—Ezetimibe—atherosclerosis	0.000615	0.00301	CcSEcCtD
Tiotropium—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000613	0.003	CcSEcCtD
Tiotropium—Hypersensitivity—Simvastatin—atherosclerosis	0.000611	0.00299	CcSEcCtD
Tiotropium—Urticaria—Niacin—atherosclerosis	0.000604	0.00296	CcSEcCtD
Tiotropium—Abdominal pain—Niacin—atherosclerosis	0.000602	0.00295	CcSEcCtD
Tiotropium—Urticaria—Pravastatin—atherosclerosis	0.000595	0.00292	CcSEcCtD
Tiotropium—Abdominal pain—Pravastatin—atherosclerosis	0.000592	0.0029	CcSEcCtD
Tiotropium—Pruritus—Simvastatin—atherosclerosis	0.000586	0.00287	CcSEcCtD
Tiotropium—Dizziness—Lovastatin—atherosclerosis	0.000586	0.00287	CcSEcCtD
Tiotropium—Dizziness—Ezetimibe—atherosclerosis	0.000575	0.00282	CcSEcCtD
Tiotropium—Vomiting—Lovastatin—atherosclerosis	0.000563	0.00276	CcSEcCtD
Tiotropium—Hypersensitivity—Niacin—atherosclerosis	0.000561	0.00275	CcSEcCtD
Tiotropium—Rash—Lovastatin—atherosclerosis	0.000559	0.00274	CcSEcCtD
Tiotropium—Dermatitis—Lovastatin—atherosclerosis	0.000558	0.00274	CcSEcCtD
Tiotropium—Headache—Lovastatin—atherosclerosis	0.000555	0.00272	CcSEcCtD
Tiotropium—Vomiting—Ezetimibe—atherosclerosis	0.000552	0.00271	CcSEcCtD
Tiotropium—Hypersensitivity—Pravastatin—atherosclerosis	0.000552	0.00271	CcSEcCtD
Tiotropium—Dizziness—Simvastatin—atherosclerosis	0.000548	0.00269	CcSEcCtD
Tiotropium—Rash—Ezetimibe—atherosclerosis	0.000548	0.00269	CcSEcCtD
Tiotropium—Dermatitis—Ezetimibe—atherosclerosis	0.000547	0.00268	CcSEcCtD
Tiotropium—Headache—Ezetimibe—atherosclerosis	0.000544	0.00267	CcSEcCtD
Tiotropium—Pruritus—Niacin—atherosclerosis	0.000538	0.00264	CcSEcCtD
Tiotropium—Pruritus—Pravastatin—atherosclerosis	0.00053	0.0026	CcSEcCtD
Tiotropium—Vomiting—Simvastatin—atherosclerosis	0.000527	0.00258	CcSEcCtD
Tiotropium—Nausea—Lovastatin—atherosclerosis	0.000526	0.00258	CcSEcCtD
Tiotropium—Rash—Simvastatin—atherosclerosis	0.000522	0.00256	CcSEcCtD
Tiotropium—Dermatitis—Simvastatin—atherosclerosis	0.000522	0.00256	CcSEcCtD
Tiotropium—Headache—Simvastatin—atherosclerosis	0.000519	0.00254	CcSEcCtD
Tiotropium—Nausea—Ezetimibe—atherosclerosis	0.000516	0.00253	CcSEcCtD
Tiotropium—Dizziness—Niacin—atherosclerosis	0.000503	0.00247	CcSEcCtD
Tiotropium—Dizziness—Pravastatin—atherosclerosis	0.000495	0.00243	CcSEcCtD
Tiotropium—Nausea—Simvastatin—atherosclerosis	0.000492	0.00241	CcSEcCtD
Tiotropium—Vomiting—Niacin—atherosclerosis	0.000484	0.00237	CcSEcCtD
Tiotropium—Rash—Niacin—atherosclerosis	0.00048	0.00235	CcSEcCtD
Tiotropium—Dermatitis—Niacin—atherosclerosis	0.000479	0.00235	CcSEcCtD
Tiotropium—Headache—Niacin—atherosclerosis	0.000477	0.00234	CcSEcCtD
Tiotropium—Vomiting—Pravastatin—atherosclerosis	0.000476	0.00233	CcSEcCtD
Tiotropium—Rash—Pravastatin—atherosclerosis	0.000472	0.00232	CcSEcCtD
Tiotropium—Dermatitis—Pravastatin—atherosclerosis	0.000472	0.00231	CcSEcCtD
Tiotropium—Headache—Pravastatin—atherosclerosis	0.000469	0.0023	CcSEcCtD
Tiotropium—Nausea—Niacin—atherosclerosis	0.000452	0.00222	CcSEcCtD
Tiotropium—Nausea—Pravastatin—atherosclerosis	0.000445	0.00218	CcSEcCtD
Tiotropium—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.99e-05	0.000254	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—HMOX1—atherosclerosis	1.98e-05	0.000253	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	1.94e-05	0.000248	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	1.93e-05	0.000247	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.92e-05	0.000246	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	1.92e-05	0.000245	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—APOB—atherosclerosis	1.89e-05	0.000242	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PDGFB—atherosclerosis	1.89e-05	0.000241	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KNG1—atherosclerosis	1.85e-05	0.000237	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KNG1—atherosclerosis	1.85e-05	0.000236	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	1.84e-05	0.000236	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AGT—atherosclerosis	1.84e-05	0.000236	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GSTM1—atherosclerosis	1.84e-05	0.000235	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	1.84e-05	0.000235	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KNG1—atherosclerosis	1.83e-05	0.000234	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	1.82e-05	0.000233	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	1.81e-05	0.000231	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—FABP4—atherosclerosis	1.81e-05	0.000231	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LCAT—atherosclerosis	1.81e-05	0.000231	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—LPL—atherosclerosis	1.81e-05	0.000231	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—APOE—atherosclerosis	1.8e-05	0.000231	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—LEP—atherosclerosis	1.8e-05	0.000231	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	1.8e-05	0.00023	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PLG—atherosclerosis	1.8e-05	0.00023	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PLG—atherosclerosis	1.79e-05	0.000229	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CAV1—atherosclerosis	1.79e-05	0.000229	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	1.78e-05	0.000228	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—APOA1—atherosclerosis	1.78e-05	0.000228	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.78e-05	0.000228	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOA4—atherosclerosis	1.77e-05	0.000227	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PLG—atherosclerosis	1.77e-05	0.000227	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—LIPC—atherosclerosis	1.77e-05	0.000226	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GPX1—atherosclerosis	1.76e-05	0.000225	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOC3—atherosclerosis	1.76e-05	0.000225	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—LDLR—atherosclerosis	1.75e-05	0.000224	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.74e-05	0.000223	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ESR1—atherosclerosis	1.72e-05	0.00022	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CD36—atherosclerosis	1.72e-05	0.00022	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CETP—atherosclerosis	1.71e-05	0.000218	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—F2—atherosclerosis	1.7e-05	0.000218	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	1.7e-05	0.000218	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	1.7e-05	0.000217	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	1.68e-05	0.000215	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MMP3—atherosclerosis	1.64e-05	0.00021	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MMP3—atherosclerosis	1.64e-05	0.000209	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.64e-05	0.000209	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF2—atherosclerosis	1.64e-05	0.000209	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF2—atherosclerosis	1.63e-05	0.000208	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	1.63e-05	0.000208	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—MTHFR—atherosclerosis	1.63e-05	0.000208	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MMP3—atherosclerosis	1.62e-05	0.000207	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF2—atherosclerosis	1.61e-05	0.000206	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.61e-05	0.000206	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PPARA—atherosclerosis	1.6e-05	0.000204	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOB—atherosclerosis	1.59e-05	0.000203	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOB—atherosclerosis	1.58e-05	0.000202	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.57e-05	0.000201	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	1.57e-05	0.000201	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOB—atherosclerosis	1.57e-05	0.0002	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EDN1—atherosclerosis	1.56e-05	0.0002	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	1.56e-05	0.000199	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EDN1—atherosclerosis	1.56e-05	0.000199	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	1.55e-05	0.000199	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCL5—atherosclerosis	1.55e-05	0.000198	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—AGT—atherosclerosis	1.55e-05	0.000198	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCL5—atherosclerosis	1.55e-05	0.000198	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.54e-05	0.000198	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EDN1—atherosclerosis	1.54e-05	0.000197	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—INS—atherosclerosis	1.54e-05	0.000197	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCL5—atherosclerosis	1.53e-05	0.000196	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.53e-05	0.000195	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.53e-05	0.000195	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOA2—atherosclerosis	1.53e-05	0.000195	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.53e-05	0.000195	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCL2—atherosclerosis	1.52e-05	0.000194	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LPL—atherosclerosis	1.52e-05	0.000194	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—APOE—atherosclerosis	1.51e-05	0.000194	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LPL—atherosclerosis	1.51e-05	0.000193	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.51e-05	0.000193	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CAV1—atherosclerosis	1.5e-05	0.000192	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—APOA1—atherosclerosis	1.5e-05	0.000191	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LPL—atherosclerosis	1.5e-05	0.000191	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IGF1—atherosclerosis	1.49e-05	0.000191	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	1.47e-05	0.000188	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	1.47e-05	0.000188	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LPA—atherosclerosis	1.46e-05	0.000186	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	1.45e-05	0.000186	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SPP1—atherosclerosis	1.44e-05	0.000184	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SPP1—atherosclerosis	1.43e-05	0.000183	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.43e-05	0.000183	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	1.42e-05	0.000182	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SPP1—atherosclerosis	1.42e-05	0.000181	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	1.42e-05	0.000181	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—BGN—atherosclerosis	1.41e-05	0.00018	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	1.41e-05	0.00018	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOA5—atherosclerosis	1.4e-05	0.000179	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.38e-05	0.000176	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CG—atherosclerosis	1.37e-05	0.000175	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NOS3—atherosclerosis	1.35e-05	0.000173	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.34e-05	0.000172	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	1.33e-05	0.00017	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	1.32e-05	0.000169	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PPARG—atherosclerosis	1.32e-05	0.000169	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	1.31e-05	0.000168	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.3e-05	0.000166	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AGT—atherosclerosis	1.3e-05	0.000166	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—INS—atherosclerosis	1.29e-05	0.000165	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AGT—atherosclerosis	1.29e-05	0.000165	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AGT—atherosclerosis	1.28e-05	0.000164	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LEP—atherosclerosis	1.27e-05	0.000162	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOE—atherosclerosis	1.27e-05	0.000162	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LEP—atherosclerosis	1.27e-05	0.000162	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOE—atherosclerosis	1.27e-05	0.000162	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CAV1—atherosclerosis	1.26e-05	0.000161	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOA1—atherosclerosis	1.26e-05	0.000161	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CAV1—atherosclerosis	1.25e-05	0.00016	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LEP—atherosclerosis	1.25e-05	0.00016	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOE—atherosclerosis	1.25e-05	0.00016	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOA1—atherosclerosis	1.25e-05	0.00016	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CAV1—atherosclerosis	1.24e-05	0.000159	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOA1—atherosclerosis	1.24e-05	0.000159	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ESR1—atherosclerosis	1.21e-05	0.000155	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ESR1—atherosclerosis	1.21e-05	0.000155	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	1.2e-05	0.000153	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—F2—atherosclerosis	1.2e-05	0.000153	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ESR1—atherosclerosis	1.2e-05	0.000153	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—F2—atherosclerosis	1.19e-05	0.000153	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALB—atherosclerosis	1.19e-05	0.000152	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—F2—atherosclerosis	1.18e-05	0.000151	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.18e-05	0.000151	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.16e-05	0.000149	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	1.16e-05	0.000148	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LIPC—atherosclerosis	1.16e-05	0.000148	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOC3—atherosclerosis	1.15e-05	0.000147	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.15e-05	0.000147	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LDLR—atherosclerosis	1.14e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	1.14e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6—atherosclerosis	1.14e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—NOS3—atherosclerosis	1.13e-05	0.000145	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	1.13e-05	0.000145	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOB—atherosclerosis	1.13e-05	0.000145	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CETP—atherosclerosis	1.12e-05	0.000143	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.1e-05	0.000141	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	1.1e-05	0.00014	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	1.09e-05	0.00014	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—INS—atherosclerosis	1.09e-05	0.000139	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MMP9—atherosclerosis	1.08e-05	0.000139	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	1.08e-05	0.000139	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—INS—atherosclerosis	1.08e-05	0.000138	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—LPL—atherosclerosis	1.08e-05	0.000138	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	1.07e-05	0.000137	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—INS—atherosclerosis	1.07e-05	0.000137	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.07e-05	0.000137	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCL2—atherosclerosis	1.07e-05	0.000137	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCL2—atherosclerosis	1.06e-05	0.000136	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	1.05e-05	0.000135	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCL2—atherosclerosis	1.05e-05	0.000135	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GPX1—atherosclerosis	1.05e-05	0.000135	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	1.05e-05	0.000135	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF1—atherosclerosis	1.05e-05	0.000134	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF1—atherosclerosis	1.05e-05	0.000134	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS2—atherosclerosis	1.04e-05	0.000133	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF1—atherosclerosis	1.04e-05	0.000133	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CD36—atherosclerosis	1.03e-05	0.000131	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.01e-05	0.000129	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	9.97e-06	0.000128	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	9.94e-06	0.000127	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	9.84e-06	0.000126	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	9.74e-06	0.000125	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.73e-06	0.000124	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—STAT3—atherosclerosis	9.64e-06	0.000123	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARA—atherosclerosis	9.54e-06	0.000122	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOS3—atherosclerosis	9.52e-06	0.000122	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOS3—atherosclerosis	9.49e-06	0.000121	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOS3—atherosclerosis	9.4e-06	0.00012	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AGT—atherosclerosis	9.24e-06	0.000118	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	9.21e-06	0.000118	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOE—atherosclerosis	9.06e-06	0.000116	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ABCA1—atherosclerosis	9e-06	0.000115	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CAV1—atherosclerosis	8.97e-06	0.000115	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOA1—atherosclerosis	8.95e-06	0.000115	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	8.94e-06	0.000114	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	8.44e-06	0.000108	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	8.42e-06	0.000108	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	8.33e-06	0.000107	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CG—atherosclerosis	8.17e-06	0.000105	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	8.16e-06	0.000104	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	8.13e-06	0.000104	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	8.05e-06	0.000103	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6—atherosclerosis	8.03e-06	0.000103	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6—atherosclerosis	8e-06	0.000102	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL6—atherosclerosis	7.92e-06	0.000101	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARG—atherosclerosis	7.89e-06	0.000101	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—INS—atherosclerosis	7.74e-06	9.9e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.72e-06	9.88e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MMP9—atherosclerosis	7.64e-06	9.77e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MMP9—atherosclerosis	7.61e-06	9.74e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	7.55e-06	9.66e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MMP9—atherosclerosis	7.54e-06	9.64e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	7.53e-06	9.63e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	7.46e-06	9.54e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	7.43e-06	9.5e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	7.41e-06	9.47e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	7.4e-06	9.47e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOB—atherosclerosis	7.4e-06	9.46e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	7.38e-06	9.44e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	7.33e-06	9.38e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	7.31e-06	9.35e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.2e-06	9.2e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALB—atherosclerosis	7.09e-06	9.07e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LPL—atherosclerosis	7.06e-06	9.03e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GPX1—atherosclerosis	6.89e-06	8.81e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	6.86e-06	8.77e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	6.83e-06	8.74e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—STAT3—atherosclerosis	6.79e-06	8.68e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—NOS3—atherosclerosis	6.78e-06	8.68e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	6.77e-06	8.66e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—STAT3—atherosclerosis	6.77e-06	8.66e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6—atherosclerosis	6.74e-06	8.62e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CD36—atherosclerosis	6.71e-06	8.58e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—STAT3—atherosclerosis	6.7e-06	8.57e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	6.49e-06	8.3e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	6.47e-06	8.27e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	6.4e-06	8.19e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.36e-06	8.13e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	6.29e-06	8.05e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	6.27e-06	8.02e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARA—atherosclerosis	6.24e-06	7.98e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AKT1—atherosclerosis	6.21e-06	7.95e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	6.21e-06	7.95e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS2—atherosclerosis	6.2e-06	7.94e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AGT—atherosclerosis	6.04e-06	7.73e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOE—atherosclerosis	5.92e-06	7.57e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CAV1—atherosclerosis	5.87e-06	7.5e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOA1—atherosclerosis	5.85e-06	7.49e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.34e-06	6.83e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—AKT1—atherosclerosis	5.22e-06	6.67e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARG—atherosclerosis	5.16e-06	6.6e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—INS—atherosclerosis	5.06e-06	6.47e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6—atherosclerosis	4.74e-06	6.07e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6—atherosclerosis	4.73e-06	6.05e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6—atherosclerosis	4.68e-06	5.99e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALB—atherosclerosis	4.64e-06	5.93e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NOS3—atherosclerosis	4.44e-06	5.67e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKT1—atherosclerosis	4.37e-06	5.6e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKT1—atherosclerosis	4.36e-06	5.58e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKT1—atherosclerosis	4.32e-06	5.52e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.06e-06	5.19e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AKT1—atherosclerosis	3.12e-06	3.99e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AKT1—atherosclerosis	2.04e-06	2.61e-05	CbGpPWpGaD
